Fixed-dose ivermectin for Mass Drug Administration: Is it time to leave the dose pole behind? Insights from an Individual Participant Data Meta-Analysis
Towards a sustainable model for a digital learning network in support of the Immunization Agenda 2030 -a mixed methods study with a transdisciplinary component
Identifying WHO global priority endemic pathogens for vaccine research and development (R&D) using multi-criteria decision analysis (MCDA): an objective of the Immunization Agenda 2030
Presentation at Pacific Regional COR-NTD Meeting, Brisbane 2024- “Multi-level integration: The PINE project experience in PNG and Vanuatu”
Minimum Service Package for the integration of female genital schistosomiasis into sexual and reproductive health and rights interventions
Implementing the Immunization Agenda 2030: a framework for action through coordinated planning, monitoring & evaluation, ownership & accountability, and communications & advocacy
Final Project Report to the End Fund on: Female Genital Schistosomiasis (FGS) Training Workshops to Catalyze Action
The Global Elimination or Eradication Acceleration Review (GEAR): Case Study on Onchocerciasis Elimination (English) (français) (português)
The development of an artificial intelligence-based digital pathology for neglected tropical diseases: a platform specific analysis of the World Health Organisation diagnosti
Compressing the Timelines for Development and Delivery: Accelerating Access to Triple-Drug Therapy to Eliminate Lymphatic Filariasis
Development and Introduction of the Filariasis Test Strip: A New Diagnostic Test for the Global Program to Eliminate Lymphatic Filariasis
Accelerating the Uptake of WHO Recommendations for Mass Drug Administration Using Ivermectin, Diethylcarbamazine, and Albendazole
Reflections on “Orchestrating for Impact”: Harmonizing across stakeholders to accelerate global health gains
Addressing a silent and neglected scourge in sexual and reproductive health in Sub-Saharan Africa by development of training competencies to improve prevention, diagnosis, and treatment of female genital schistosomiasis (FGS) for health workers
White Paper: Lessons from working across public health programs and a proposal for how to facilitate further cross-program collaboration to achieve NTD goals
White Paper: Elimination and Eradication of disease: what have we learned from past successes and failures and how that can guide us in future efforts
Questions and Answers (Q & A) for Female Genital Schistosomiasis Workshop (English, French & Portuguese)
